XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Series A convertible preferred stock
Accumulated Deficit
Series A convertible preferred stock
Series A convertible preferred stock
Common Stock Member
Additional Paid-In Capital Member
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance (in Value) at Dec. 31, 2017   $ 65.0     $ 277.9 $ 7.3 $ 0.9 $ 351.1
Balance (in Shares) at Dec. 31, 2017   650,000   48,712,288        
Exercise of stock options (in Value)         0.1     0.1
Exercise of stock options (in shares)       5,000        
Exercised of warrants (in shares)       2        
Vesting of restricted stock units (in Value)         (0.4)     (0.4)
Vesting of restricted stock units (in Shares)       84,516        
Series A convertible preferred stock dividend     $ (4.9)          
Stock-based compensation expense         3.6     3.6
Issuance of common stock         104.5     104.5
Issuance of common stock (in shares)       10,653,368        
Issuance of earnout shares         48.2 (48.2)   48.2
Issuance of earnout shares (in shares)       5,000,000        
Foreign currency translation adjustments             (1.8) (1.8)
Net income (loss)           (5.2)   (5.2)
Balance (in Value) at Dec. 31, 2018   $ 65.0     433.9 (51.0) (0.9) 447.0
Balance (in Shares) at Dec. 31, 2018   650,000   64,455,174        
Vesting of restricted stock units (in Value)         (0.2)     (0.2)
Vesting of restricted stock units (in Shares)       133,901        
Series A convertible preferred stock dividend $ (5.0) $ (5.0)            
Stock-based compensation expense         3.8     3.8
Foreign currency translation adjustments             0.5 0.5
Net income (loss)           (307.4)   (307.4)
Balance (in Value) at Dec. 31, 2019   $ 65.0     437.5 (363.4) (0.4) 138.7
Balance (in Shares) at Dec. 31, 2019   650,000   64,589,075        
Exercised of warrants (in shares)       1        
Vesting of restricted stock units (in Value)         (0.1)     (0.1)
Vesting of restricted stock units (in Shares)       434,098        
Series A convertible preferred stock dividend $ (4.9) $ (4.9)            
Stock-based compensation expense         4.8     4.8
Foreign currency translation adjustments             $ 0.4 0.4
Net income (loss)           6.2   6.2
Balance (in Value) at Dec. 31, 2020   $ 65.0     $ 442.2 $ (362.1)   $ 145.1
Balance (in Shares) at Dec. 31, 2020   650,000   65,023,174